David P. Nelson

3.5k total citations
42 papers, 2.3k citations indexed

About

David P. Nelson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, David P. Nelson has authored 42 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in David P. Nelson's work include Mechanical Circulatory Support Devices (7 papers), Nitric Oxide and Endothelin Effects (6 papers) and Cardiac Arrest and Resuscitation (6 papers). David P. Nelson is often cited by papers focused on Mechanical Circulatory Support Devices (7 papers), Nitric Oxide and Endothelin Effects (6 papers) and Cardiac Arrest and Resuscitation (6 papers). David P. Nelson collaborates with scholars based in United States, Australia and Guatemala. David P. Nelson's co-authors include Paul T. Schumacker, L. D. Wood, R. W. Samsel, Steven M. Schwartz, Anthony Chang, Thomas L. Spray, David Wessel, John F. Kocsis, Gil Wernovsky and Timothy M. Hoffman and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

David P. Nelson

42 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David P. Nelson United States 25 790 761 684 574 392 42 2.3k
A. B. J. Groeneveld Netherlands 25 737 0.9× 964 1.3× 414 0.6× 613 1.1× 296 0.8× 82 2.6k
Angela McLuckie United Kingdom 14 638 0.8× 636 0.8× 381 0.6× 399 0.7× 229 0.6× 23 1.8k
Barbara Friesenecker Austria 26 694 0.9× 755 1.0× 404 0.6× 741 1.3× 604 1.5× 62 2.6k
Donald L. Bredle United States 26 1.0k 1.3× 960 1.3× 526 0.8× 480 0.8× 312 0.8× 56 2.3k
Ilse Milants Belgium 10 447 0.6× 1.2k 1.6× 347 0.5× 626 1.1× 245 0.6× 13 3.8k
Katia Donadello Belgium 30 1.1k 1.4× 1.5k 2.0× 527 0.8× 406 0.7× 645 1.6× 99 3.3k
Lars J. Bjertnæs Norway 23 538 0.7× 469 0.6× 376 0.5× 793 1.4× 363 0.9× 89 2.0k
Edward Stachowski Australia 16 364 0.5× 782 1.0× 311 0.5× 330 0.6× 342 0.9× 22 2.3k
Anders Oldner Sweden 22 445 0.6× 497 0.7× 293 0.4× 379 0.7× 359 0.9× 83 1.8k
Raphaël Favory France 24 525 0.7× 922 1.2× 350 0.5× 293 0.5× 359 0.9× 71 2.3k

Countries citing papers authored by David P. Nelson

Since Specialization
Citations

This map shows the geographic impact of David P. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Nelson more than expected).

Fields of papers citing papers by David P. Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Nelson. The network helps show where David P. Nelson may publish in the future.

Co-authorship network of co-authors of David P. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Nelson. A scholar is included among the top collaborators of David P. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Nelson. David P. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staveski, Sandra, et al.. (2019). Reducing Exposure to Opioid and Benzodiazepine Medications for Pediatric Cardiac Intensive Care Patients: A Quality Improvement Project*. Pediatric Critical Care Medicine. 20(4). 340–349. 15 indexed citations
2.
Kwiatkowski, David M., Shina Menon, Catherine D. Krawczeski, et al.. (2014). Improved outcomes with peritoneal dialysis catheter placement after cardiopulmonary bypass in infants. Journal of Thoracic and Cardiovascular Surgery. 149(1). 230–236. 57 indexed citations
3.
Plenter, Robert J., Todd J. Grazia, David P. Nelson, et al.. (2014). Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4+ T-cell mediated rejection. Cellular Immunology. 293(1). 30–33. 7 indexed citations
4.
Moffett, Brady S., et al.. (2011). Enteral potassium supplementation in a pediatric cardiac intensive care unit: Evaluation of a practice change. Pediatric Critical Care Medicine. 12(5). 552–554. 7 indexed citations
5.
Nelson, David P., Dean B. Andropoulos, & Charles D. Fraser. (2008). Perioperative Neuroprotective Strategies. Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual. 11(1). 49–56. 22 indexed citations
6.
Moffett, Brady S., Antonio R. Mott, David P. Nelson, Stuart L. Goldstein, & John L. Jefferies. (2008). Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review. Pediatric Critical Care Medicine. 9(4). 403–406. 29 indexed citations
7.
Checchia, Paul A., Ronald A. Bronicki, John M. Costello, & David P. Nelson. (2005). Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers*. Pediatric Critical Care Medicine. 6(4). 441–444. 77 indexed citations
8.
Duffy, Jodie Y., David P. Nelson, Steven M. Schwartz, et al.. (2004). Glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets. Pediatric Critical Care Medicine. 5(1). 28–34. 21 indexed citations
9.
Nelson, David P., Steven M. Schwartz, & Anthony Chang. (2004). Neonatal physiology of the functionally univentricular heart. Cardiology in the Young. 14(S1). 52–60. 16 indexed citations
10.
Jiang, Yang, Steven P. Jones, Toshimitsu Suhara, et al.. (2003). Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart. Journal of Biological Chemistry. 278(17). 15185–15191. 35 indexed citations
11.
Duke, Richard C., et al.. (2002). Murine heart transgenic Fas ligand expression protects against allograft rejection. Transplantation Proceedings. 34(8). 3396–3398. 2 indexed citations
12.
Nelson, David P., Stephanie Burns Wechsler, Takuya Miura, et al.. (2002). Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion. The Annals of Thoracic Surgery. 73(1). 156–162. 26 indexed citations
13.
Pearl, Jeffrey M., David P. Nelson, Steven M. Schwartz, & Peter B. Manning. (2002). First-stage palliation for hypoplastic left heart syndrome in the twenty-first century. The Annals of Thoracic Surgery. 73(1). 331–339. 57 indexed citations
14.
Pearl, Jeffrey M., David P. Nelson, Steven M. Schwartz, et al.. (2002). Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts. The Annals of Thoracic Surgery. 74(3). 830–837. 43 indexed citations
15.
Hoffman, Timothy M., Gil Wernovsky, Andrew M. Atz, et al.. (2002). Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal. 143(1). 15–21. 98 indexed citations
16.
Pearl, Jeffrey M., et al.. (2001). Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. The Annals of Thoracic Surgery. 72(2). 565–570. 19 indexed citations
17.
Schermerhorn, Marc L., Motohisa Tofukuji, Philip R. Khoury, et al.. (2000). Sialyl LewisX oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs. Journal of Thoracic and Cardiovascular Surgery. 120(2). 230–237. 12 indexed citations
18.
Nelson, David P., D. Greg Hall, Steven M. Schwartz, et al.. (2000). Proinflammatory consequences of transgenic Fas ligand expression in the heart. Journal of Clinical Investigation. 105(9). 1199–1208. 73 indexed citations
19.
Pearl, Jeffrey M., et al.. (2000). Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics. Journal of Thoracic and Cardiovascular Surgery. 119(5). 931–938. 24 indexed citations
20.
Pearl, Jeffrey M., et al.. (1999). Bosentan prevents hypoxia-reoxygenation–induced pulmonary hypertension and improves pulmonary function. The Annals of Thoracic Surgery. 68(5). 1714–1721. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. B. J. Groeneveld Breakdown of academic impact, for papers by Angela McLuckie Breakdown of academic impact, for papers by Barbara Friesenecker Breakdown of academic impact, for papers by Donald L. Bredle Breakdown of academic impact, for papers by Ilse Milants Breakdown of academic impact, for papers by Katia Donadello Breakdown of academic impact, for papers by Lars J. Bjertnæs Breakdown of academic impact, for papers by Edward Stachowski Breakdown of academic impact, for papers by Anders Oldner Breakdown of academic impact, for papers by Raphaël Favory
Rankless by CCL
2026